PF614-MPAR is a prodrug of oxycodone that includes a trypsin inhibitor that blocks the activation and release of the opioid if too much of the product is consumed. The Food and Drug Administration ...
Supplemental regional anesthesia may reduce opioid use in patients following microvascular free flap reconstruction of the oral cavity, according to a study published in the Journal of Oral and ...
Current guidelines recommend that pregnant women with opioid use disorder be prescribed either methadone or buprenorphine, but these drugs too have significant potential for abuse. A recent study ...
PHOENIX — Certain minority populations may be at a higher absolute risk of being prescribed opioids after undergoing dermatologic surgery, according to a new study. The study also found that patients ...
The Iowa Dental Board has suspended the license and the general anesthesia permit for an oral surgeon who allegedly diverted patients' opioids for his own personal use, according to a settlement ...
Immunofluorescence staining of a tumor section from a patient with oral cancer. Human oral cancer cells (white) express abundant EGFR (red) within the tumor and in the adjacent peripheral nerve (green ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. Food and Drug Administration ...
Please provide your email address to receive an email when new articles are posted on . AvertD is the first test approved by the FDA to evaluate an elevated risk for developing opioid use disorder.
Inside the Nice pharmacy on Allegheny Avenue in Kensington, employees busily fill prescriptions for waiting customers. (Kimberly Paynter/WHYY) From Philly and the Pa. suburbs to South Jersey and ...
A group of 31 physicians and researchers called on the FDA to reverse its decision about AvertD, a test that uses DNA to identify whether adults may have an elevated risk of developing opioid use ...
The U.S. Food and Drug Administration has approved the first test for assessing the risk of opioid use addiction in specific individuals. It is a prescription-use only genetic laboratory test intended ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. The Centers for Disease Control and Prevention (CDC) recently released its yearly examination of deaths attributed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results